2022
DOI: 10.1016/s0169-5002(22)00122-2
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the use of next generation sequencing for directing treatment for patients with advanced non-small cell lung cancer (NSCLC): a single centre experience from University Hospitals Birmingham NHS Foundation Trust (UHB)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles